BioCorRx (BICX) Other Working Capital Changes (2011 - 2026)

BioCorRx has disclosed Other Working Capital Changes across 16 years of filings, most recently posting -$13388.0 for Q1 2026.

• Other Working Capital Changes for Q1 2026 came in at -$13388.0, down 37.79% year-over-year; the trailing twelve-month figure through Mar 2026 was $59165.0 (up 273.19% YoY), and the FY2025 annual result was $52500.0, down 57.37% from the prior year.
• Other Working Capital Changes came in at -$13388.0 for Q1 2026 at BioCorRx, down from $29741.0 in the prior quarter.
• In the past five years, Other Working Capital Changes ranged from a high of $69958.0 in Q1 2022 to a low of -$93570.0 in Q4 2022.
• The 5-year median for Other Working Capital Changes is $5000.0 (2025), against an average of -$7452.4.
• Across the five-year window, Other Working Capital Changes jumped 289.2% in 2022 and plunged 730.29% in 2024, its largest moves.
• BioCorRx's Other Working Capital Changes stood at -$93570.0 in 2022, then soared by 48.2% to -$48467.0 in 2023, then jumped by 208.38% to $52528.0 in 2024, then sank by 43.38% to $29741.0 in 2025, then slumped by 145.02% to -$13388.0 in 2026.
• The last three Other Working Capital Changes figures came in at -$13388.0 (Q1 2026), $29741.0 (Q4 2025), and $5000.0 (Q3 2025), per Business Quant data.